SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
SpaceX Starship Test Flight Reaches New Heights but Ends in Setback 
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment 
Tabletop particle accelerator could transform medicine and materials science 
Astronomers have discovered another puzzling interstellar object − this third one is big, bright and fast 
NASA Partners with Katalyst to Save Swift Observatory with Innovative Docking Mission 
Is space worth the cost? Accounting experts say its value can’t be found in spreadsheets 
FDA Adds Fatal Risk Warning to J&J and Legend Biotech’s Carvykti Cancer Therapy 
Lost in space: MethaneSat failed just as NZ was to take over mission control – here’s what we need to know now 
Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026 
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage 
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment 
Right now, the best that humans could hope for in terms of their lifespan is to reach the age of 100 or perhaps even a few years beyond that. According to the Gompertz mortality law, which is basically a model to calculate the mortality of humans, this only makes sense because death depends on certain factors that can’t be changed. A team of researchers at the Gero biotech firm recently published their study, which essentially challenged this misconception.
Putting it simply, Gompertz law uses what’s called the Strehler-Mildvan (SM) correlation in order to explain mortality, which is basically the sum of two factors that will inevitably increase on an exponential level as people age, Futurism reports. The team at Gero looked into this correlation and found that it had no factual basis despite the fact that it has practically been accepted for over five decades.
This concept was popularized back in the 60s when it was published in the journal Science. It really put scientists who wanted to extend human life in a bind as well because the SM correlation suggests that trying to prolong life while young will have the effect of actually shortening lifespan. According to the study that the Gero team published, this is simply not the case.
Titled “Strehler-Mildvan correlation is a degenerate manifold of Gompertz fit,” the study basically argues that the conclusion derived from the SM correlation has no actual basis in biology. In a press release, the team’s public face Peter Fedichev noted how this study will impact research into extending human life.
“Elimination of SM correlation from theories of aging is good news, because if it was not just negative correlation between Gompertz parameters, but the real dependence, it would have banned optimal anti-aging interventions and limited human possibilities to life extension,” Fedichev said.
Basically, scientists are now free to research the ways to increase human lifespan. In fact, they could potentially extend it as much as they want.
